Perceptive Informatics Introduces New Randomization and Trial Supply Management Reporting for Improved Data Access and Decision-Making

Boston, MA, June 18, 2009 -

Perceptive Informatics, the industry’s leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has introduced a new reporting solution as part of its ClinPhone Randomization and Trial Supply Management (RTSM) technologies, which offer validated randomization methods, automated inventory control, dispensing and titration management, and emergency code break capabilities. The reporting solution features a Universal Report Suite to monitor trial management performance, RTSM Dashboard with trending and forecasting functionalities, and Self-Service Module with customizable search criteria for power users who are focused on in-depth data analysis.

"Our customers are facing increasing complexity and globalization of their clinical studies, often resulting in significant timeline and supply pressures. To assist them, Perceptive Informatics offers sophisticated technologies supporting their requirements for more robust reporting and enabling faster strategic decision-making," said Todd Kole, Vice President, IVRS Business, Perceptive Informatics. "Our RTSM reporting solution has been designed to help monitor trial progress and provide efficient access to study data and metrics."

"We have incorporated extensive, valuable input from our clients as well as Perceptive’s experience in providing automated randomization and trial supply management technologies for thousands of clinical trials into the development of this new feature-rich RTSM reporting solution," said Nikki Dowlman, Ph.D., Product Manager, Perceptive Informatics. "The solution offers powerful reporting functionalities for various trial management roles to help answer key questions through intelligent analysis and presentation of trial randomization and supply management data."

The new RTSM reporting solution features three modules:
 

  • A Universal Report Suite, which offers a comprehensive collection of ready-made, validated reports that can be quickly configured for individual study needs. The reports provide key performance metrics, presenting an accurate snapshot of study progress including recruitment and trial supply status.
  • An RTSM Dashboard, which provides high level metrics and forecasting data, including access to key performance indicators for analyzing trends to inform decision-making. Metrics include supplies utilization forecasting and production planning as well as recruitment forecasting and progress against targets.
  • A Self-Service Module, which allows users to create and download their own tailored data sets from a live study database for performing complex or specialized analyses.


Perceptive’s RTSM reporting solution is designed for optimal performance to allow quick and efficient access to study data and metrics through advanced functionalities. Its features include the ability to create and export graphs or charts containing key study data, and download data in a variety of formats including Microsoft Excel, Microsoft PowerPoint, PDF and Active HTML files. The solution also allows users to download and share reports for local display and data queries using a snapshot of the live database. Graphical displays of trends and forecasts in a user-friendly, interactive online format enable rapid information assimilation and enhanced data interpretation.

For more information about the capabilities of the ClinPhone RTSM reporting solution, visit: http://www.perceptive.com/ClinPhone-RTSM/RTSM-Reporting-Solution.html.

 

About Perceptive Informatics
Perceptive Informatics, a subsidiary of PAREXEL, is the industry’s leading eClinical solutions provider. Perceptive Informatics offers access to innovative eClinical technologies and resources, providing clinical trial sponsors, CROs, and other service providers with the benefits of an extensive line of products and services throughout the entire clinical development lifecycle. In August, 2008 Perceptive was joined with ClinPhone plc, and the newly combined organization offers eClinical software and services that increase the efficiency and productivity of clinical research. Perceptive’s expansive product portfolio includes Interactive Voice and Web Response Systems (IVRS/IWRS), Medical Imaging, Electronic Data Capture (EDC) systems, Clinical Trial Management Systems (CTMS) and Electronic Patient Reported Outcomes (ePRO) solutions, as well as eClinical systems integration and implementation services. For more information about Perceptive Informatics, visit www.perceptive.com.

 

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company’s actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company’s recognition of revenue included in backlog; the Company’s dependence on certain industries and clients; the Company’s ability to win new business, manage growth and costs, and attract and retain employees; the Company’s ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company’s business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled “Risk Factors” of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 as filed with the SEC on May 8, 2009, which “Risk Factors” discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company’s estimates as of the date of this release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.
 

Media Contacts




RSS Events RSS Feed

RSS News RSS Feed